Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byAstraZeneca
Price$440M
Date10/2013

General Information

Offices

London, GBR
The QMB Innovation Centre
London, E1 2AX, GBR

People

Tags

Spirogen

Spirogen is a clinical stage biotechnology company specialising in novel, sequence-selective, DNA minor groove-binding molecules with potent therapeutic properties. Spirogen’s principal technology involves modification of members of a group of naturally occurring antibiotics called pyrrolobenzodiazepines (PBDs). The company was founded in 2000, has 18 employees and is private equity funded.

Recent Milestones

Videos

Screenshots

Spirogen screenshot
Above: Home page
Uploaded: 10/15/13

Sources

  1. AstraZeneca buys oncology-focused Spirogen for up to $440 million (reuters.com) [edit]
Edit This Page
Last Edited 4/9/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy